Effective bronchodilator resuscitation of children in the emergency room: Device or interface?

Respiratory Care

Volumn 56, Issue 6, 2011, Pages 882-885

  Ari, Arzu ^a   Fink, James B ^a  

^a GEORGIA STATE UNIVERSITY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

BRONCHODILATING AGENT; GAMMA INTERFERON; SALBUTAMOL;

ARTICLE; ASTHMA; BREATH ACTUATED NEBULIZER; CHILD HEALTH CARE; DISEASE EXACERBATION; DRUG DELIVERY SYSTEM; EMERGENCY WARD; EXPIRATORY FLOW RATE; HUMAN; INDIVIDUALIZATION; INSPIRATORY CAPACITY; INTERMETHOD COMPARISON; LARGE VOLUME JET NEBULIZER; MEDICAL INSTRUMENTATION; MEDICAL NEBULIZER; METERED DOSE INHALER; OFF LABEL DRUG USE; PARTICLE SIZE; PATIENT PREFERENCE; RESUSCITATION; SMALL VOLUME JET NEBULIZER; TREATMENT OUTCOME;

ADMINISTRATION, INHALATION; ALBUTEROL; ASTHMA; BRONCHODILATOR AGENTS; CHILD; CHILD, PRESCHOOL; EMERGENCY SERVICE, HOSPITAL; EQUIPMENT DESIGN; HUMANS; INFANT; NEBULIZERS AND VAPORIZERS;

EID: 79960673249     PISSN: 00201324     EISSN: 19433654     Source Type: Journal    
DOI: 10.4187/respcare.01375     Document Type: Article

References (26)

1. Kelly H, Keim K, McWilliams B. Comparison of two methods of delivering continuously nebulized albuterol. Ann Pharmacother 2003; 37(1):23-26.
2. Papo MC, Frank J, Thompson AE. A prospective, randomized study of continuous versus intermittent nebulized albuterol for severe status asthmaticus in children. Crit Care Med 1993;21(10): 1479-1486.
3. Khine H, Fuchs SM, Saville AL. Continuous vs intermittent nebulized albuterol for emergency management of asthma. Acad Emerg Med 1996;3(11):1019-1024.
4. Camargo CA Jr, Spooner CH, Rowe BH. Continuous versus intermittent beta-agonists in the treatment of acute asthma. Cochrane Database Syst Rev 2003;(4):CD001115.
5. Fink J, Dhand R. Bronchodilator resuscitation in the emergency department, part 1: device selection. Respir Care 1999;44(10):1353-1374.
6. Reisner C, Kotch A, Dworkin G. Continuous versus frequent intermittent nebulization of albuterol in acute asthma: a randomized prospective study. Ann Allergy Asthma Immunol 1995;75(1): 41-47.
7. Berlinski A, Willis JR, Leisenring T. In-vitro comparison of 4 largevolume nebulizers in 8 hours of continuous nebulization. Respir Care 2010;55(12):1671-1679.
8. Ari A, Hess D, Myers TR, Rau JL. A guide to aerosol delivery devices for respiratory therapists, 2nd edition. Irving, TX: American Association for Respiratory Care; 2009. http://www.aarc.org/education/aerosol_devices/aerosol_delivery_guide2.pdf. Accessed April 12, 2011.
9. Rau JL, Ari A, Restrepo RD. Performance comparison of nebulizer designs: constant-output, breath-enhanced, and dosimetric. Respir Care 2004;49(2):174-179.
10. Sangwan S, Condos R, Smaldone G. Lung deposition and respirable mass during wet nebulization. J Aerosol Med 2003;16(4): 379-386.
11. Sabato K, Ward P, Hawk W, Gildengorin V, Asselin JM. Randomized controlled trial of a breath-actuated nebulizer in pediatric asthma patients in the emergency department. Respir Care 2011;56(6):761-770.
12. Benton G, Thomas RC, Nickerson BG, McQuitty JC, Okikawa J. Experience with a metered-dose inhaler with a spacer in the pediatric emergency department. Am J Dis Child 1989;143(6):678-681.
13. Esposito-Festen JE, Ates B, van Vliet FJ, Verbraak AF, de Jongste JC, Tiddens HA. Effect of a facemask leak on aerosol delivery from a pMDI-spacer system. J Aerosol Med 2004;17(1):1-6.
14. Smaldone GC, Sangwan S, Shah A. Facemask design, facial deposition, and delivered dose of nebulized aerosols. J Aerosol Med 2007;20(Suppl 1):S66-S75.
15. Rau JL, Smaldone GC. The interface between the device and the patient: masks, mouthpieces, and "others". Introduction. J Aerosol Med 2007;20(Suppl 1):S1-S2.
16. Janssens H, Tiddens H. Aerosol therapy: the special needs of young children. Pediatr Respir Rev 2006;7(Suppl 1):S83-S85.
17. Janssens HM, Tiddens HA. Facemasks and aerosol delivery by metered dose inhaler-valved holding chamber in young children: a tight seal makes the difference. J Aerosol Med 2007;20(Suppl 1):S59-S63.
18. Erzinger S, Schueepp KG, Brooks-Wildhaber J, Devadason SG, Wildhaber JH. Facemasks and aerosol delivery in vivo. J Aerosol Med 2007;20(Suppl 1):S78-S83
19. Restrepo RD, Dickson SK, Rau JL, Gardenhire DS. An investigation of nebulized bronchodilator delivery using a pediatric lung model of spontaneous breathing. Respir Care 2006;51(1):56-61.
20. Lin HL, Restrepo RD, Gardenhire DS, Rau JL. Effect of face mask design on inhaled mass of nebulized albuterol, using a pediatric breathing model. Respir Care 2007;52(8):1021-1026.
21. Rubin BK. Bye-bye, blow-by (editorial). Respir Care 2007;52(8): 981.
22. Everard ML. Inhaler devices in infants and children: challenges and solutions. J Aerosol Med 2004;17(2):186-195.
23. Everard ML. Aerosol delivery to children. Pediatr Ann 2006;35(9): 630-636.
24. Janssens H, van der Wiel E, Verbraak A, de Jongste J, Merkus P, Tiddens H. Aerosol therapy and the fighting toddler: is administration during sleep an alternative? J Aerosol Med 2003;16(4):395-400.
25. Ari A, Harwood R, Sheard M, Dailey P, Fink JB. In vitro comparison of heliox and oxygen in aerosol delivery using pediatric high flow nasal cannula. Pediatr Pulmonol 2011;[Epub ahead of print]. doi: 10.1002/ppul.21421
26. Bhashyam AR, Wolf MT, Marcinkowski AL, Saville A, Thomas K, Carcillo JA, Corcoran TE. Aerosol delivery through nasal cannulas: an in vitro study. J Aerosol Med Pulm Drug Deliv 2008;21(2):181-188.